ArticleBMC public health2025
Classification of risk for transmission of vaccine-preventable diseases in Brazilian municipalities: comparative analysis before and after the national movement for vaccination and multivaccination proposed by the Ministry of Health as of 2023.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spatial analysis of meningococcal c vaccination coverage in children in BRAZIL between 2012 and 2024.BMC pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the classification of the risk of transmission of vaccine-preventable diseases in Brazilian municipalities before and after the National Movement for Vaccination and Multivaccination proposed by the Ministry of Health.
methodsThis is an epidemiological, ecological study using secondary data on vaccination coverage, dropout rates, and homogeneity of vaccination coverage (HCV) for ten immunobiologicals recommended for children under 2 years of age. The study aims to compare the years 2022 and 2023 in Brazil. The vaccination coverage index (VCI), HCV, and dropout rate (DR) were evaluated in the municipalities of Brazil in the years 2022 and 2023. The municipalities were classified into risk strata for transmission of vaccine-preventable diseases before and after the strategy proposed by the Ministry of Health.
resultsThe study found an increase in median vaccination coverage (VC) for all vaccines evaluated, except for the varicella vaccine. Regarding HCV, in 2022, 27.99% of Brazilian municipalities were classified as adequate (≥ 70%), and 410 (7.36%) achieved 100% HCV for all vaccines. In 2023, 34.90% of municipalities were classified as adequate (≥ 70%), and among them, 582 (10.46%) achieved 100% HCV for all vaccines. In terms of the risk classification for the transmission of vaccine-preventable diseases, Brazil had 72.01% of municipalities classified as high or very high risk in 2022, which decreased to 65.13% in 2023. As for municipalities classified as low or very low risk, 11.27% fell into this category in 2022, increasing to 18.12% in 2023.
conclusionThe study concludes that VC surveillance, in conjunction with the Microplanning for High-Quality Vaccination Activities methodology developed by the Ministry of Health in 2023, played a crucial role in resuming immunization efforts that had been hindered by science denialism and the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.